HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Total Current Liabilities came in at $315.8 million in Q4 2025, down 7.76% on a QoQ basis from $342.3 million in Q2 2025.

HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 11 years of Total Current Liabilities data on file, last reported at $315.8 million in Q4 2025.

  • On a quarterly basis, Total Current Liabilities changed N/A year-over-year to $315.8 million in Q4 2025; TTM through Dec 2025 was $315.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $315.8 million, changed N/A from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $315.8 million, down from $342.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for HCM reached as high as $373.3 million in Q2 2024 and fell as low as $188.5 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $310.7 million across 5 years, with a median of $321.9 million in 2022.
  • Across the five-year window, Total Current Liabilities surged 107.49% in 2021 and decreased 8.29% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $311.7 million in 2021, then grew by 13.55% to $353.9 million in 2022, then retreated by 3.68% to $340.9 million in 2023, then increased by 9.51% to $373.3 million in 2024, then slipped by 15.41% to $315.8 million in 2025.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $315.8 million in Q4 2025, $342.3 million in Q2 2025, and $373.3 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - 315.78 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 315.78 Mn
Jun 30, 2025 342.35 Mn
Jun 30, 2024 373.29 Mn
Jun 30, 2023 340.86 Mn
Dec 31, 2022 353.90 Mn
Jun 30, 2022 321.86 Mn
Dec 31, 2021 311.66 Mn
Jun 30, 2021 247.72 Mn
Mar 31, 2021 188.52 Mn
Dec 31, 2020 158.40 Mn
Jun 30, 2020 119.39 Mn
Dec 31, 2019 113.10 Mn
Sep 30, 2019 105.35 Mn
Jun 30, 2019 110.61 Mn
Mar 31, 2019 101.33 Mn
Dec 31, 2018 85.48 Mn
Jun 30, 2018 84.58 Mn
Dec 31, 2017 104.60 Mn
Jun 30, 2017 96.84 Mn
Dec 31, 2016 95.12 Mn